Skip to main content
São Paulo Medical Journal logoLink to São Paulo Medical Journal
. 2022 Feb 7;140(2):250–260. doi: 10.1590/1516-3180.2021.0367.R1.23072021

Effects and implications of the COVID-19 pandemic on medicine use by employees of a Brazilian public university: a cross-sectional study

Waléria de Paula I,, Wanessa Cecília de Oliveira II, Adriana Lúcia Meireles III, Renata Cristina Rezende Macedo do Nascimento IV, Glenda Nicioli da Silva V
PMCID: PMC9610238  PMID: 35137907

Abstract

BACKGROUND:

During the COVID-19 pandemic, universities have had to adopt remote education, a strategy that caused sudden changes of routine for everyone involved in academia.

OBJECTIVE:

To assess the profile of medicine use by the employees of a Brazilian public university during the COVID-19 pandemic.

DESIGN AND SETTING:

Cross-sectional study at a Brazilian public university.

METHODS:

Employees were invited to answer an online self-administered questionnaire, containing questions on sociodemographic features, medicine use, mental health and lifestyle habits during the COVID-19 pandemic. The outcome variable was the use of medicines stratified according to occupation. Descriptive, bivariate and multivariate (Poisson regression) statistical analyses were performed.

RESULTS:

A total of 372 employees participated in the study and use of medicine was reported by 53.2%. Among professors, suicide attempts (prevalence ratio [PR], 1.81; 95% confidence interval [CI], 1.20-2.74), physical activity (PR, 1.53; 95% CI, 1.11-2.11) and poor self-rated health (PR, 1.29; 95% CI, 1.01-1.66); and among technicians, decreased workload during the COVID-19 pandemic (PR, 1.41; 95% CI, 1.00-1.99), excess body weight (PR, 1.39; 95% CI, 1.02-1.88) and poor self-rated health (PR, 1.48; 95% CI, 1.14-1.92) were positively associated with use of medicines. In addition, among technicians, engaging in physical activity (PR, 0.60; 95% CI, 0.46-0.78) was a protective factor against medicine use.

CONCLUSION:

The profile of medicine use among these employees was similar to that of the Brazilian population. However, some associated factors may have been influenced by the COVID-19 pandemic, thus highlighting the need to examine this topic in a longitudinal study.

KEY WORDS (MeSH terms): Drug utilization, COVID-19, Universities, Faculty, Pharmacoepidemiology

AUTHORS’ KEY WORDS: Medicine use, University professors, Technicians

INTRODUCTION

The COVID-19 pandemic, caused by exponential transmission of the severe acute respiratory syndrome coronavirus 2, has had serious consequences worldwide.1,2 In Brazil, since the first case was reported, the number of infections and deaths has been increasing, reaching 18,557,141 confirmed cases on June 30, 2021, at 7 pm. The average numbers of cases and deaths have tended to fluctuate considerably among Brazil’s states and regions. However, the southeastern region currently (2021) has the highest moving average of COVID-19 cases.3

In order to reduce the transmission rates, some coping measures have been adopted, such as quarantine or social distancing,4,5 and Brazilian universities have adopted distance learning. This strategy has caused sudden changes to the routines of all people involved in academia.6

In this context, professors and technicians who carry out face-to-face activities with students have had to adapt to a new reality and develop new teaching skills. These changes associated with social distancing may have affected these employees’ mental health because they normally interact with different people as part of their workload. Additionally, the feeling of anxiety related to an unstable future may have led to mental health issues among those who faced such situations.7,8 This situation had the potential to increase their use of psychotropic medicines. In addition, data from the Federal Pharmacy Council (Conselho Federal de Farmácia, CFF) indicated that the use of psychotropic medicines during the pandemic (January to July 2020), especially medicines in the anticonvulsant and antidepressant classes, increased by 12.8% and 13.84%, respectively.9

To the best of our knowledge, no study has explored the use of medicines among employees of higher education institutions during the COVID-19 pandemic and whether the profile of medicine use by this specific population is similar to that of the general adult population.

OBJECTIVE

The aim of the present study was to assess the profile of medicines consumed by the employees of a Brazilian public university during the COVID-19 pandemic and the factors associated with this use of medicines.

METHODS

Study design and participants

This cross-sectional study was integrated with a project on anxiety and depression among university students (PADu) that was conducted by researchers at the Universidade Federal de Ouro Preto (UFOP), titled “Effect of the COVID-19 pandemic on mental and nutritional health and on the home food environment of the academic community: longitudinal evaluation - PADu-COVID”. Currently, UFOP has 11,993 students enrolled in 55 undergraduate courses, 726 technicians (administrative and laboratory technicians) and 934 professors. The study population consisted of all technicians and professors at UFOP.10

For this article, only employees (university professors and technicians) were evaluated, and the participants were recruited through a virtual invitation. This constituted convenience sampling, in which all employees were invited by email to participate and the sample consisted of those who answered the questionnaire.

Ethical issues

All potential participants were asked to read and agree to the informed consent statement online before they could participate in the study. A copy of this statement was made available for download. This step was necessary before they could start answering the questionnaire. The PADu-COVID project received ethical approval under number CAAE 31077320.7.1001.5150 on June 28, 2020.

Data collection

The employees’ e-mail addresses were obtained through the UFOP Information Technology Center. These e-mail addresses were used with the university’s consent. Information about this study was also spread via the university’s website, social networks, unions and academic directories that supported the project.

All UFOP employees were invited to participate in the study between July 20 and August 27, 2020, through virtual invitations sent out by email and through social network channels, using snowball sampling. The questionnaire was made available on an online platform (Google Forms) and the invitations were sent out once a week, on alternate days, over a period of one month.

Outcome and explanatory variables

The questionnaire consisted of questions on sociodemographic characteristics, medicine use, mental health, lifestyles and health conditions during the COVID-19 pandemic. The outcome variable of the study was the use of medicines by the employees. The data on this variable was obtained through the question: “In the last 30 days, have you taken any medicine?”. The answer options were “no” or “yes”. If the response was yes, the participant was asked to report the name of the medicine. Subsequently, the medicines reported were grouped into classes in accordance with the second level of Anatomical Therapeutic Chemical (ATC).11

The explanatory variables were the following: age (< 45 years or ≥ 45 years); sex (female or male); sexual orientation (heterosexual, homosexual, bisexual or asexual); housing situation (living alone, with family/relatives, in student housing or with friends); skin color (white; or others: East Asian, brown or black); marital status (single/divorced/widowed, married or common-law marriage); religious belief (no or yes); family income (up to six minimum monthly wages in Brazil or greater than or equal to six minimum monthly wages in Brazil); decreased income due to the pandemic (no, yes or yes, more than 50%); symptoms of anxiety (no or yes), depression (no or yes), stress (no or yes) or suicidal ideation (no or yes), or suicide attempts (no or yes) or social distancing (no or yes); workload (still the same, increased or decreased); alcohol consumption (no or yes) and alcohol consumption since the pandemic started (still the same, increased or decreased); smoking (never smoked, quit smoking or currently smoking); illicit drug use (no or yes); engaging with physical activity (no or yes); body mass index (no excess body weight or excess body weight); and self-rated health (good or poor).

The monetary values for the monthly minimum wage were presented in Brazilian reais, converted into United States dollars (USD) using the purchasing power parity (PPP) method. Thus, the value of 1 USD was equivalent to 2.25 Brazilian reais, according to the conversion rate for the year 2019.12

Statistical analyses

The data from the survey questionnaire were automatically stored in a database in the Excel software, 2019 version (Microsoft, Washington, United States) and were coded. Statistical analyses were performed using the STATA 13.0 software (StataCorp LLC, Texas, United States), namely:

  1. Descriptive analysis according to frequencies.

  2. Bivariate analysis according to Pearson’s chi-square and Fisher’s exact tests, to determine associations between the outcome of interest, i.e. medicine use stratified according to occupation, and the sociodemographic, mental health, lifestyle and health condition variables during the COVID-19 pandemic. Only the explanatory variables that showed an association with a level of significance of ≤ 0.20 in the bivariate analysis were included in the subsequent multivariate analysis.

  3. Multivariate analysis using Poisson regression was carried out to determine the possible factors associated with the use of medicine. For this analysis, a significance level of 0.05 was adopted. In the multiple regression model, the data entry method of backward selection was used, i.e. all the variables selected in the bivariate analysis were inserted at the same time in the model and were removed one-by-one, starting from the least significant. The final model was adjusted for age and sex.

RESULTS

A total of 372 employees participated in the study: 213 university professors and 159 technicians. Most of the participants were younger than 45 years (66.1%), female (56.4%), heterosexual (90.9%), living with their family (76.4%), of self-declared white skin color (59.4%) and married (60.0%); and had a religious belief (71.0%) and a family income greater than or equal to six minimum monthly wages in Brazil (81.4%). In addition, 60.7% of the participants did not experience any decrease in family income during the COVID-19 pandemic (Table 1).

Table 1. Descriptive analysis on sociodemographic variables, medicine use, mental health conditions and lifestyle habits during the COVID-19 pandemic, among employees of the Universidade Federal de Ouro Preto, Ouro Preto, 2020 (n = 372).

Variables n %
Sociodemographic characteristics
Age
 < 45 years 246 66.1
 ≥ 45 years 126 33.9
Occupation
 University professor 212 57.0
 Technicians 169 43.0
“Gratified” functions
 No 322 86.6
 Yes 50 13.4
Sex
 Female 210 56.4
 Male 162 43.6
Sexual orientation
 Heterosexual 338 90.9
 Homosexual, bisexual, and asexual 34 9.1
Housing situation
 Living alone 57 15.3
 With family/relatives 284 76.4
 In student housing or with friends 31 8.3
Skin color
 White 221 59.4
 Others (East Asian, brown or black) 151 40.6
Marital status
 Single/divorced/widowed 149 40.0
 Married or common-law marriage 223 60.0
Religious belief
 No 108 29.0
 Yes 264 71.0
Family income
 Up to six minimum monthly wages in Brazil 69 18.6
 Greater than or equal to six minimum monthly wages in Brazil 303 81.4
Income decrease due to pandemic
 No 226 60.7
 Yes 142 38.2
 Yes, more than 50% 4 1.1
Use of medicines
Were medicines used?
 No 174 46.8
 Yes, 1-4 188 50.5
 Yes, 5 or more 10 2.7
Cardiovascular medicines
 No 328 88.2
 Yes 44 11.8
Nervous system medicines
 No 309 83.1
 Yes 63 16.9
Mental health
Symptoms of anxiety
 No 307 82.5
 Yes 65 17.5
Symptoms of depression
 No 287 77.2
 Yes 85 22.8
Symptoms of stress
 No 288 77.4
 Yes 84 22.6
Suicidal ideation
 No 314 84.4
 Yes 58 15.6
Suicide attempt
 No 365 98.1
 Yes 7 1.9
Lifestyle and health conditions during the COVID-19 pandemic
Social distancing
 No 22 5.9
 Yes 350 94.1
After the start of the pandemic, your workload was:
 Still the same 140 37.6
 Increased 79 21.3
 Decreased 153 41.1
Alcohol consumption
 No 123 33.1
 Yes 249 66.9
After the start of the pandemic, your alcohol consumption was:
 Still the same 160 64.3
 Increased 34 13.6
 Decreased 55 22.1
Smoking
 No, I never smoked 305 82.0
 I quit smoking 39 10.5
 I currently smoke 28 7.5
Illicit drug use
 No 356 95.7
 Yes 16 4.3
Physical activity
 No 103 27.7
 Yes 269 72.3
Body mass index
 No excess body weight 202 54.3
 Excess body weight 170 45.7
Self-rated health
 Good SRH 308 82.8
 Poor SRH 64 17.2

One Brazilian minimum monthly wage was equivalent to 464.44 United States dollars, when converted according to purchasing power parity (PPP $) in 2019.12

Common-law marriage: long-lasting, public affective relationship between two individuals who want to build a family, as acknowledged through the Brazilian Federal Constitution.13,14

SRH: self-rated health.

“Gratified” functions are those involving direction, leadership, advisory or secretariat functions, among others, which give rise to additional payments.

Regarding the use of medicines, 53.2% of the employees took some medicine, among whom 2.7% used five or more medicines simultaneously, known as polypharmacy. Furthermore, the professors reported using 183 medicines, of which 37 (20.2%) were prescribed after the onset of the COVID-19 pandemic; the technicians reported using 149 medicines, of which 25 (16.8%) were prescribed after the onset of the pandemic. Psychotropic medicines were the most frequently used medicines, especially after the onset of the pandemic, and antiepileptics (N03), antidepressants (N06) and analgesics (N02) were the most frequently cited pharmacological classes.

Antidepressants were the most widely used medicines. Among the professors and technicians, the prevalences of antidepressant use were 13.7% and 16.8%, respectively. Analgesics were also widely cited by the participants, at a prevalence rate of 9.3% among the professors and 10.1% among the technicians. Among cardiovascular system medicines, the most frequently cited ones were angiotensin II antagonists, at a prevalence of 11.5% among the professors and 10.1% among the technicians. The percentages of medicines used, in accordance with the first and second levels of Anatomical Therapeutic Chemical (ATC), by professors and technicians, are presented in Figure 1. Medicines for the nervous and cardiovascular systems were the ones most frequently reported by the professors and technicians.

Figure 1. Prevalence of medicine use among technicians and professors, according to the first and second levels of Anatomical Therapeutic Chemical (ATC).11 .

Figure 1.

The frequencies of medicine use, stratified according to occupation, in relation to sociodemographic, mental health and lifestyle variables during the COVID-19 pandemic, are shown in Table 2.

Table 2. Bivariate analysis on the prevalence of medicine use, stratified according to occupation, in relation to sociodemographic variables, medicine use, mental health conditions and lifestyle habits during the COVID-19 pandemic among employees of the Universidade Federal de Ouro Preto, Ouro Preto, 2020 (n = 372).

Variables Use of medicines
University professor (%) P Technicians (%) P
Sociodemographic characteristics
Age
 < 45 years 46.6 < 0.001 42.6 0.009
 ≥ 45 years 71.9 65.9
“Gratified” functions
 No 56.3 0.911 46.4 0.083
 Yes 55.2 66.7
Sex
 Female 61.3 0.280 62.6 < 0.001
 Male 50.0 30.9
Sexual orientation
 Heterosexual 53.6 0.055* 49.3 0.846
 Homosexual, bisexual and asexual 84.2 46.7
Housing situation
 Living alone 48.3 0.611* 32.1 0.123
 With family/relatives 57.1 51.7
 In student housing or with friends 64.3 58.8
Skin color
 White 54.8 0.503 53.3 0.308
 Others (East Asian, brown or black) 59.7 45.2
Marital status
 Single/divorced/widowed 50.7 0.253 47.5 0.693
 Married or common-law marriage 59.0 50.6
Religious belief
 No 52.7 0.435 38.2 0.155
 Yes 58.3 52.0
Family income
 Up to six minimum monthly wages in Brazil 60.0 0.619* 45.3 0.438
 Greater than or equal to six minimum monthly wages in Brazil 56.2 51.6
Income decrease due to pandemic
 No 56.6 0.361* 43.3 0.091*
 Yes 57.3 55.2
 Yes, more than 50% 0.0 100.0
Mental health
Symptoms of anxiety
 No 54. 0.103 44.5 0.020
 Yes 67.6 67.7
Symptoms of depression
 No 54.7 0.340 47.0 0.389
 Yes 62.8 54.8
Symptoms of stress
 No 56.5 0.905 45.0 0.073
 Yes 55.6 61.5
Suicidal ideation
 No 53.4 0.049 50.7 0.303
 Yes 71.4 39.1
Suicide attempt’
 No 55.3 0.055* 49.0 0.742*
 Yes 100.0 50.0
Lifestyle and health conditions during the COVID-19 pandemic
Social distancing
 No 60.0 0.540* 58.3 0.357*
 Yes 56.2 48.3
After the start of the pandemic, your workload was:
 Still the same 54.0 0.885 39.4 0.091
 Increased 58.1 52.1
 Decreased 57.4 60.0
Alcohol consumption
 No 59.1 0.587 59.6 0.046
 Yes 55.1 43.1
After the start of the pandemic, your alcohol consumption was:
 Still the same 54.8 0.307* 46.3 0.661
 Increased 70.6 35.3
 Decreased 48.6 38.9
Smoking
 No, I never smoked 56.3 0.684* 48.8 0.925
 I quit smoking 61.5 53.8
 I currently smoke 46.1 46.7
Illicit drug use
 No 56.2 0.540 49.7 0.359*
 Yes 60.0 33.3
Physical activity
 No 41.8 0.012 72.9 < 0.001
 Yes 61.4 38.7
Body mass index
 No excess body weight 51.7 0.128 36.9 0.001
 Excess body weight 62.1 62.7
Self-rated health
 Good SRH 53.4 0.060 40.9 < 0.001
 Poor SRH 70.3 88.9

One Brazilian minimum monthly wage was equivalent to 464.44 United States dollars, when converted according to purchasing power parity (PPP $) in 2019.12

Common-law marriage: long-lasting, public affective relationship between two individuals who want to build a family, as acknowledged through the Brazilian Federal Constitution.13,14SRH: self-rated health.

“Gratified” functions are those involving direction, leadership, advisory or secretariat functions, among others, which give rise to additional payments.

*Value obtained through Fisher’s exact test.

In the bivariate analysis (Table 2), statistically significant differences were observed between university professors who used medicines and the variables of age, suicidal ideation and physical activity. Among the technicians, this association occurred in relation to the variables of age, sex, symptoms of anxiety, alcohol consumption, physical activity, body mass index and self-rated health.

The results from the multivariate analysis for medicine use stratified according to occupation were adjusted for age and sex in order to minimize possible confounding factors (Table 3). Among the professors, suicide attempts (prevalence ratio [PR], 1.81; 95% CI, 1.20-2.74), physical activity (PR, 1.53; 95% CI, 1.11-2.11) and poor self-rated health (PR, 1.29; 95% CI, 1.01-1.66) were positively associated with the use of medicines.

Table 3. Multivariate analysis using Poisson regression adjusted for sex and age, according to the occupation of employees of the Universidade Federal de Ouro Preto, Ouro Preto, 2020 (n = 372).

Variables Use of medicines
University professor Technicians
PR (95% CI) P PR (95% CI) P
Suicide attempt
 No 1 0.005
 Yes 1.81 (1.20-2.74)
After the start of the pandemic, your workload was:
 Still the same 1
 Increased 1.19 (0.84 - 1.68) 0.316
 Decreased 1.41 (1.00 - 1.99) 0.047
Physical activity
 No 1 0.009 1 < 0.001
 Yes 1.53 (1.11-2.11) 0.60 (0.46 - 0.78)
Body mass index
 No excess body weight 1 0.035
 Excess body weight 1.39 (1.02-1.88)
Self-rated health
 Good SRH 1 0.040 1 0.003
 Poor SRH 1.29 (1.01-1.66) 1.48 (1.14-1.92)

SRH = self-rated health; PR = prevalence ratio; 95% CI = 95%

Among the technicians, decreased workload during the COVID-19 pandemic (PR, 1.41; 95% CI, 1.00-1.99), excess body weight (PR, 1.39; 95% CI, 1.02-1.88) and poor self-rated health (PR, 1.48; 95% CI, 1.14–1.92) were associated with increased medicine use. On the other hand, physical activity (PR, 0.60; 95% CI, 0.46-0.78) was negatively associated with medicine use, thus indicating that it was a protective factor against medicine use (Table 3).

DISCUSSION

To the best of our knowledge, this was the first study to assess the use of medicines by the employees of a Brazilian public university during the COVID-19 pandemic. Important results were found for this population.

The results showed that there was high prevalence of medicine use among these employees (53.23%). Corroborating our findings, the National Survey on Access, Use and Promotion of Rational Use of Medicines of 2015 (Pesquisa Nacional de Acesso, Utilização e Promoção do Uso Racional de Medicamentos, PNAUM), which investigated the use of medicines in a representative sample of the Brazilian population, found an overall prevalence of medicine use of 50.70%.15 In addition, other studies on adult populations found similar overall prevalences of medicine use.16,17 In our study, medicines for the nervous and cardiovascular systems were the ones most cited, as also observed in other studies involving adult populations.18,19

de Mesquita Mororó et al. analyzed population-based data from the National Health Survey and found that access to medicines is unequal between the regions of Brazil and that higher education levels are related to increased access.20 This aspect of education, as a determinant of access to medicines, has also been found in other studies.21,22 However, despite the fact that access to medicines is linked to their profile of use, the prevalence of medicine use among the population in the present study was similar to that reported in studies involving the adult population in general.

For these university professors and technicians, the prevalence of use of new medicines after the pandemic started was around 31%. Use of psychotropic medicines was frequently reported, with emphasis on antiepileptics, analgesics and antidepressants. High use of medicines for mental health issues is a common response to moments of crisis, such as the COVID-19 pandemic. In a systematic review conducted by Xiong et al. (2020), the negative impacts on the mental health of individuals during this period were highlighted, especially the indications for pharmacological treatment.23 Thus, the COVID-19 pandemic may have contributed to the beginning of the use of this class of medicines in the UFOP academic community.

Chronic non-communicable diseases, such as hypertension, diabetes mellitus and other comorbidities, are known to be risk factors for the occurrence of severe symptoms of COVID-19.2426 In the present study, medicines for the cardiovascular system formed the second most reported class. Use of some cardiovascular medicines, such as angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers may be associated with severe COVID-19 infection.25,27 Mehra et al. (2020) indicated that cardiovascular diseases themselves and not the use of medicines are related to increased mortality among patients hospitalized with COVID-19. Thus, several independent authorities have recommended that the use of these medicines should not be interrupted among patients with COVID-19, considering the absence of robust clinical evidence.28

The use of medicines during the pandemic by the professors and technicians was associated with several socioeconomic, mental health, lifestyle and physical health condition characteristics during the COVID-19 pandemic. Among the professors, suicide attempts, physical activity and poor self-rated health were associated with the use of medicines.

Many professors experienced mental illnesses during the COVID-19 pandemic, as they entered an environment of great pressure and had to adapt to new technological and digital resources quickly, while reconciling remote work and personal life in the same environment.29 Stress in the work environment is associated with occurrence of mental disorders and can be a risk factor for use of antidepressants.30

Physical activity was associated with increased use of medicines among the professors. The association between physical activity and increased medicine use may have been influenced by the presence of chronic cardiovascular diseases among the professors and the recommendations to remain active to ensure good quality of life.31,32

Poor self-rated health was associated with increased use of medicines among the professors. In a systematic review carried out during the COVID-19 pandemic, Vindegaard and Benros (2020) observed that negative self-assessment of health can lead to an increased risk of psychiatric symptoms or worsening of psychological wellbeing, which consequently leads to use of medicines.33 In addition, the presence of comorbidities was also associated with negative self-rated health.34

For the technicians, the decrease in the workload during the pandemic, excess body weight and poor self-rated health were associated with increased use of medicines, while physical activity was a protective factor against use of medicines. The decrease in the workload, which occurred in the first months of the COVID-19 pandemic, coincided with the period of data collection. This variable was associated with increased use of medicines among the technicians. During this period, the employees had to adapt to a new scenario; they also had to face a loss of daily routines and impaired personal and social contacts. In addition, the pandemic period was accompanied by the emergence of heightened emotions, especially the fear of contracting or transmitting COVID-19. When academic activities were being organized for distance learning, this may have provided some leisure initially, but it eventually led to high levels of stress and anxiety while waiting for new ways of working.35,36 Consequently, it may have become necessary to start pharmacological treatment in order to minimize psychological damage.

Another factor associated with the use of medicines among technicians was excess body weight. Overweight and obesity are related to the presence of chronic diseases such as cardiovascular diseases.37,38 As a large percentage of the technicians reported using cardiovascular medicines, this may explain the association between being overweight and use of medicines. Similar to the professors’ profile of use, poor self-rated health was associated with increased medicine use among technicians. This relationship can be explained by the fact that, in most cases, the medicine use was directly related to disease conditions, thus resulting in poor self-perception of health.39,40

Physical activity was associated with reduced use of medicines among the technicians. It is known that physical activity prevents the onset of numerous diseases and, consequently, it may have been a protective factor. The relationship between engagement with physical activity and good health has been widely described in the literature.41,42 Good physical and mental health may reduce the need for psychotropic medications.

Although these two classes of employees showed medicine use profiles similar to that of the general population, there were differences in the characteristics associated with the use of medicines, such as the relationship between suicide attempts and use of medicines among the professors and between decreased workload and increased use of medicines among the technicians. Such associations may have been impacted by the COVID-19 pandemic. In order to better understand the profile of medicine use and the differences between these employees, it is necessary to continue the present study in a longitudinal manner.

This study had a cross-sectional design, so the influence of memory bias when reporting medicine use in the last 30 days cannot be ruled out. Data relating to additional occupations such as participation in working groups or postgraduate programs were not collected. In addition, there are many challenges in collecting online data, such as limitations on access to and reliability of the internet network, high non-response rate, selection bias toward those who have access to the internet and familiarity with the platform used for the research. The response rate was 22.6%, which was similar to what is expected for studies involving online surveys.43,44 Despite these challenges, online studies have proven to be an important alternative for conducting research during the COVID-19 pandemic.45

Lastly, this was an innovative study that highlighted the importance of studies involving employees of educational institutions, especially regarding medicine use and health status, risks of intoxication and addiction, masked symptoms and delayed diagnoses.46,47

CONCLUSION

The results from this study showed that there was high prevalence of medicine use among the professors and technicians at an important public university in Brazil. Although the population studied had a high level of education, the prevalence of medicine use was similar to that of the general population in Brazil. However, it is worth emphasizing that different factors were associated with medicine use among the university professors and technicians, compared with the adult population in general, such as suicide attempts and decreased workload.

Although studies on medicine use are still very scarce, they are very important for understanding the profile of the active user population, demonstrating the role of medicines as necessary inputs for healthcare actions, rationalizing costs and improving the quality and case resolution capacity of the local healthcare system. Educational institutions should seek to understand the circumstances of their employees and should carry out pharmaceutical counseling with regard to rational use of medicines during and after the COVID-19 pandemic. In addition, studies in which it is sought to understand the effects of the pandemic on medicine use need to be continued, considering that irrational use of medicines can lead to health risks.

Acknowledgements

The authors thank the ‘Grupo de Pesquisa e Estudo em Nutrição e Saúde Coletiva’ (GPENSC), the ‘Projeto de Ansiedade e Depressão em universitários’ (PADu) and Universidade Federal de Ouro Preto (UFOP) for all their support.

Footnotes

Universidade Federal de Ouro Preto (UFOP), Ouro Preto (MG), Brazil

Sources of funding: This study was supported by Universidade Federal de Ouro Preto (PROPP 23/2019; grant number 23109.004079/2019-53) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) (Research Productivity Scholarship; grant number 310905/2020-6)

REFERENCES

  • 1.Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed. 2020;91(1):157–60. doi: 10.23750/abm.v91i1.9397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-33. doi: 10.1056/NEJMoa2001017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Ministério da Saúde, Brasil . Boletins Epidemiológicos. 2021. Available from: https://www.gov.br/saude/pt-br/assuntos/boletins-epidemiologicos. [Google Scholar]
  • 4.Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD. How will country-based mitigation measures influence the course of the COVID-19 epidemic? Lancet. 2020;395(10228):931–4. doi: 10.1016/S0140-6736(20)30567-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Organização Pan-americana da Saúde - OPAS. Folha informativa sobre COVID-19 . 2020. Available from: https://www.paho.org/bra/index.php?option=com_content&view=article&id=6101:covid19&I%20temid=875. [Google Scholar]
  • 6.Gusso HL, Archer AB, Luiz FB, et al. Ensino superior em tempos de pandemia: diretrizes à gestão universitária. Educ Soc. 2020;41:e238957. doi: 10.1590/es.238957. [DOI] [Google Scholar]
  • 7.Faro A, Bahiano MdA, Nakano TdC, et al. COVID-19 e saúde mental: a emergência do cuidado. Estud Psicol. 2020;37:e200074. doi: 10.1590/1982-0275202037e200074. [DOI] [Google Scholar]
  • 8.Hodges C, Moore S, Lockee B, Trust T, Bond A. The Difference Between Emergency Remote Teaching and Online Learning. 2020. Available from: https://er.educause.edu/articles/2020/3/the-difference-between-emergency-remote-teaching-and-online-learning. [Google Scholar]
  • 9.Conselho Federal de Farmácia - CFF . Venda de medicamentos psiquiátricos cresce na pandemia. 2020. Available from: http://covid19.cff.org.br/venda-de-medicamentos-psiquiatricos-cresce-na-pandemia/ [Google Scholar]
  • 10.Universidade Federal de Ouro Preto - UFOP . UFOP em números. 2020. Available from: https://ufop.br/ufop-em-numeros. [Google Scholar]
  • 11.Who Collaborating Centre for Drug Statistics Methodology . ATC/DDD Index. 2021. Available from: https://www.whocc.no/atc_ddd_index/ [Google Scholar]
  • 12.The World Bank . PPP conversion factor. 2019. Available from: https://data.worldbank.org/indicator/PA.NUS.PPP. [Google Scholar]
  • 13.Brasil . Constituição da República Federativa do Brasil: promulgada em 5 de outubro de 1988. 1988. Available from: https://www.senado.leg.br/atividade/const/con1988/CON1988_05.10.1988/CON1988.asp. [Google Scholar]
  • 14.Brasil. Lei nº 10.406, de 10 de janeiro de 2002 . Institui o Código Civil. 2002. Available from: http://www.planalto.gov.br/ccivil_03/leis/2002/L10406compilada.htm. [Google Scholar]
  • 15.Bertoldi AD, Pizzol TD, Ramos LR, et al. Sociodemographic profile of medicines users in Brazil: results from the 2014 PNAUM survey. Rev Saude Publica. 2016;50(suppl 2):5s. doi: 10.1590/S1518-8787.2016050006119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Carvalho MF, Pascom AR, Souza-Junior PR, Damacena GN, Szwarcwald CL. Utilization of medicines by the Brazilian population, 2003. Cad Saude Publica. 2005;21(Suppl):100–8. doi: 10.1590/s0102-311x2005000700011. [DOI] [PubMed] [Google Scholar]
  • 17.Bertoldi AD, de Barros AJ, Wagner A, Ross-Degnan D, Hallal PC. Medicine access and utilization in a population covered by primary health care in Brazil. Health Policy. 2009;89(3):295–302. doi: 10.1016/j.healthpol.2008.07.001. [DOI] [PubMed] [Google Scholar]
  • 18.Sans S, Paluzie G, Puig T, Balañá L, Balaguer-Vintró I. Prevalencia del consumo de medicamentos en la población adulta de Cataluña. Gac Sanit. 2002;16(2):121–30. doi: 10.1016/S0213-9111(02)71643-9. [DOI] [PubMed] [Google Scholar]
  • 19.Galvao TF, Silva MT, Gross R, Pereira MG. Medication use in adults living in Brasilia, Brazil: a cross-sectional, population-based study. Pharmacoepidemiol Drug Saf. 2014;23(5):507–14. doi: 10.1002/pds.3583. [DOI] [PubMed] [Google Scholar]
  • 20.de Mesquita Mororó IMM, de Oliveira Santos EG, de Souza TA, de Almeida Medeiros A, Barbosa IR. Desigualdades no acesso a medicamentos no Brasil: um estudo de base populacional. Res Soc Dev. 2020;9(10):e5319108952-e. doi: 10.33448/rsd-v9i10.8952. [DOI] [Google Scholar]
  • 21.Paniz VM, Fassa AG, Facchini LA, et al. [Access to continuous-use medication among adults and the elderly in South and Northeast Brazil] Cad Saude Publica. 2008;24(2):267–80. doi: 10.1590/s0102-311x2008000200005. [DOI] [PubMed] [Google Scholar]
  • 22.Boing AC, Bertoldi AD, Boing AF, Bastos JL, Peres KG. [Access to medicines in the public sector: analysis of users of the Brazilian Unified National Health System] Cad Saude Publica. 2013;29(4):691–701. [PubMed] [Google Scholar]
  • 23.Xiong J, Lipsitz O, Nasri F, et al. Impact of COVID-19 pandemic on mental health in the general population: A systematic review. J Affect Disord. 2020;277:55–64. doi: 10.1016/j.jad.2020.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Alhazzani W, Moller MH, Arabi YM, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19) Intensive Care Med. 2020;46(5):854–87. doi: 10.1007/s00134-020-06022-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8(4):e21. doi: 10.1016/S2213-2600(20)30116-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–42. doi: 10.1001/jama.2020.2648. [DOI] [PubMed] [Google Scholar]
  • 27.Nicin L, Abplanalp WT, Mellentin H, et al. Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts. Eur Heart J. 2020;41(19):1804–6. doi: 10.1093/eurheartj/ehaa311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. 2020;382(25):e102. doi: 10.1056/NEJMoa2007621. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 29.Shaw K. Colleges expand VPN capacity, conferencing to answer COVID-19. 2020. Available from: https://www.networkworld.com/article/3535415/colleges-expand-vpn-capacity-conferencing-to-answer-covid-19.html. [Google Scholar]
  • 30.Virtanen M, Honkonen T, Kivimaki M, et al. Work stress, mental health and antidepressant medication findings from the Health 2000 Study. J Affect Disord. 2007;98(3):189–97. doi: 10.1016/j.jad.2006.05.034. [DOI] [PubMed] [Google Scholar]
  • 31.Rejeski WJ, Mihalko SL. Physical activity and quality of life in older adults. J Gerontol A Biol Sci Med Sci. 2001;56(Spec No 2):23–35. doi: 10.1093/gerona/56.suppl_2.23. [DOI] [PubMed] [Google Scholar]
  • 32.Bize R, Johnson JA, Plotnikoff RC. Physical activity level and health-related quality of life in the general adult population: a systematic review. Prev Med. 2007;45(6):401–15. doi: 10.1016/j.ypmed.2007.07.017. [DOI] [PubMed] [Google Scholar]
  • 33.Vindegaard N, Benros ME. COVID-19 pandemic and mental health consequences: Systematic review of the current evidence. Brain Behav Immun. 2020;89:531–42. doi: 10.1016/j.bbi.2020.05.048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Pavao AL, Werneck GL, Campos MR. [Self-rated health and the association with social and demographic factors, health behavior, and morbidity: a national health survey] Cad Saude Publica. 2013;29(4):723–34. doi: 10.1590/S0102-311X2013000400010. [DOI] [PubMed] [Google Scholar]
  • 35.Brooks SK, Webster RK, Smith LE, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395(10227):912–20. doi: 10.1016/S0140-6736(20)30460-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Zhou X, Snoswell CL, Harding LE, et al. The Role of Telehealth in Reducing the Mental Health Burden from COVID-19. Telemed J E Health. 2020;26(4):377–9. doi: 10.1089/tmj.2020.0068. [DOI] [PubMed] [Google Scholar]
  • 37.Khan SS, Ning H, Wilkins JT, et al. Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity. JAMA Cardiol. 2018;3(4):280–7. doi: 10.1001/jamacardio.2018.0022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Piche ME, Poirier P, Lemieux I, Despres JP. Overview of Epidemiology and Contribution of Obesity and Body Fat Distribution to Cardiovascular Disease: An Update. Prog Cardiovasc Dis. 2018;61(2):103–13. doi: 10.1016/j.pcad.2018.06.004. [DOI] [PubMed] [Google Scholar]
  • 39.Mavaddat N, Valderas JM, van der Linde R, Khaw KT, Kinmonth AL. Association of self-rated health with multimorbidity, chronic disease and psychosocial factors in a large middle-aged and older cohort from general practice: a cross-sectional study. BMC Fam Pract. 2014;15:185. doi: 10.1186/s12875-014-0185-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Lorem GF, Schirmer H, Wang CE, Emaus N. Ageing and mental health: changes in self-reported health due to physical illness and mental health status with consecutive cross-sectional analyses. BMJ Open. 2017;7(1):e013629. doi: 10.1136/bmjopen-2016-013629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Rhodes RE, Janssen I, Bredin SSD, Warburton DER, Bauman A. Physical activity: Health impact, prevalence, correlates and interventions. Psychol Health. 2017;32(8):942–75. doi: 10.1080/08870446.2017.1325486. [DOI] [PubMed] [Google Scholar]
  • 42.Warburton DER, Bredin SSD. Health benefits of physical activity: a systematic review of current systematic reviews. Curr Opin Cardiol. 2017;32(5):541–56. doi: 10.1097/HCO.0000000000000437. [DOI] [PubMed] [Google Scholar]
  • 43.Fincham JE. Response rates and responsiveness for surveys, standards, and the Journal. Am J Pharm Educ. 2008;72(2):43. doi: 10.5688/aj720243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Manfreda KL, Bosnjak M, Berzelak J, Haas I, Vehovar V. Web surveys versus other survey modes: A meta-analysis comparing response rates. International journal of market research. 2008;50(1):79–104. doi: 10.1177/147078530805000107. [DOI] [Google Scholar]
  • 45.Salvador PTCdO, Alves KYA, Rodrigues CCFM. Online data collection strategies used in qualitative research of the health field: a scoping review. Rev Gaucha Enferm. 2020;41:e20190297. doi: 10.1590/1983-1447.2020.20190297. [DOI] [PubMed] [Google Scholar]
  • 46.Asseray N, Ballereau F, Trombert-Paviot B, et al. Frequency and severity of adverse drug reactions due to self-medication: a cross-sectional multicentre survey in emergency departments. Drug Saf. 2013;36(12):1159–68. doi: 10.1007/s40264-013-0114-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Sousa LAO, Fonteles MMF, Monteiro MP, et al. Prevalence and characteristics of adverse drug events in Brazil. Cad Saude Publica. 2018;34(4):e00040017. doi: 10.1590/0102-311X00040017. [DOI] [PubMed] [Google Scholar]

Articles from São Paulo Medical Journal are provided here courtesy of Associação Paulista de Medicina

RESOURCES